
Switzerland’s KOF Barometer recently hit its highest reading since 2021, which points to broader business conditions that many investors may find encouraging. When growth expectations improve, attention often shifts to companies that analysts already expect to grow earnings strongly from a solid financial base. This article highlights three stocks from the Healthy high growth potential screener that fit that profile and may deserve a closer look now.
The three stocks covered below are just a small sample of this theme. The full screen surfaces 283 more companies that analysts expect to grow earnings strongly while maintaining acceptable financial positions. To see the complete set and start identifying your own highest conviction ideas, go straight to the Healthy high growth potential screener.
Overview: Marvell Technology designs and supplies semiconductors that power modern data centers, with a focus on Ethernet switches, network adapters and high performance storage controllers that handle heavy cloud and enterprise storage workloads. These data center networking and storage products are the clearest link to the Healthy high growth potential theme, as they sit in parts of the infrastructure where analysts currently see strong multi year earnings growth potential.
Market Cap: US$211.7 billion
Investors looking at Marvell Technology today are really looking at the plumbing of AI and cloud data centers, where Ethernet switches, optical interconnects and storage controllers are expected to carry multi year earnings growth. Analysts forecast earnings and revenue growth near 30% a year, helped by expanding partnerships with hyperscalers such as Google and other large cloud customers, and recent Q2 2027 results highlighted stronger demand for AI focused custom silicon and networking. The catch is that the stock trades on a premium P/E and has shown high price volatility, so any disappointment on AI data center spending, one off items or margins could hit sentiment. For investors comfortable with those risks, the story behind that growth forecast is worth a closer look.
Marvell Technology’s AI plumbing story centers on aggressive earnings expectations supported by hyperscaler demand, while the premium P/E and volatility keep many investors cautious. Get the full context in the analyst forecasts for Marvell Technology
Overview: Rocket Lab is a space company that provides small and medium class rocket launches through its Electron and developing Neutron vehicles, alongside spacecraft design, satellite manufacturing and on orbit management services for commercial, government and constellation customers. Its strongest link to the Healthy high growth potential theme is the launch services and related space systems work that analysts expect to support multi year earnings expansion as more satellites and constellations are deployed.
Operations: Rocket Lab generates around US$225 million from Launch Services and about US$544 million from its larger Space Systems segment, where it supplies satellites, components and related services.
Market Cap: US$40.4 billion
Rocket Lab offers a way to access the expanding space economy, with earnings forecast to grow 65.09% a year and revenue expected to rise 25.3% a year as Electron launches, the developing Neutron rocket and a growing backlog in space systems and defense contracts build scale. The company is still loss making with a reported decline in Return on Equity and relies on external funding, and shareholders have seen dilution and recent insider selling, so execution and capital discipline matter. Analysts expect profitability within 3 years, and a share price that screens as trading well below a DCF based fair value estimate may leave room for upside if Neutron milestones, new government contracts and integration moves like the Iridium deal progress as planned.
Rocket Lab’s accelerating earnings forecasts and space exposure are only half the story. See how the valuation, funding needs and Neutron execution risk all fit together in the analysis report for Rocket Lab
Overview: Oracle is a global enterprise software and cloud company that helps businesses run core functions such as finance, HR and supply chains through its Oracle Fusion Cloud SaaS suite and NetSuite, while also offering database, AI enabled cloud infrastructure and industry specific applications. The clearest link to the Healthy high growth potential theme comes from these cloud applications and subscriptions, along with Oracle Cloud Infrastructure and Autonomous Database, which are expected to support multi year earnings growth as customers move from on premise licenses to recurring cloud services.
Operations: Oracle generates the bulk of its revenue from Cloud and software at about US$58.5b, with smaller contributions from Services at around US$5.7b and Hardware at roughly US$3.1b.
Market Cap: US$437.7b
Oracle gives you exposure to one of the largest cloud and AI transition stories, anchored by Fusion Cloud and NetSuite subscription growth and reinforced by a very large AI infrastructure backlog that points to multi year earnings potential. Analysts expect earnings to grow around 24% a year over the next 3 years and see scope for upside if that backlog converts to revenue efficiently, yet the stock still trades on a P/E below many large software peers. The catch is that this cloud and AI build out is being funded with heavy debt and capex, which affects margins, raises credit risk indicators and keeps dividend coverage tight. For investors comfortable weighing those funding and execution risks against the growth runway, Oracle’s combination of cloud applications and AI infrastructure may deserve closer attention.
Oracle’s cloud and AI earnings story is accelerating, while a heavy debt load and capex raise questions. Read the Oracle financial health report to see whether that growth engine or the balance sheet has the final word.
Markets move fast and the most interesting breakout ideas do not stay under the radar for long. Scan these fresh stock lists before the momentum is caught elsewhere and consider your options promptly.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com